nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—ulcerative colitis—rectum cancer	0.954	1	CtDrD
Mesalazine—CHUK—epithelium—rectum cancer	0.00291	0.0674	CbGeAlD
Mesalazine—CHUK—renal system—rectum cancer	0.0027	0.0626	CbGeAlD
Mesalazine—CHUK—female reproductive system—rectum cancer	0.00216	0.0501	CbGeAlD
Mesalazine—IKBKB—smooth muscle tissue—rectum cancer	0.0019	0.0442	CbGeAlD
Mesalazine—IKBKB—urethra—rectum cancer	0.0018	0.0418	CbGeAlD
Mesalazine—IKBKB—mammalian vulva—rectum cancer	0.00171	0.0398	CbGeAlD
Mesalazine—ALOX5—smooth muscle tissue—rectum cancer	0.00158	0.0366	CbGeAlD
Mesalazine—ALOX5—urethra—rectum cancer	0.00149	0.0346	CbGeAlD
Mesalazine—IKBKB—female reproductive system—rectum cancer	0.00147	0.0341	CbGeAlD
Mesalazine—MPO—epithelium—rectum cancer	0.00139	0.0321	CbGeAlD
Mesalazine—IKBKB—vagina—rectum cancer	0.00133	0.0308	CbGeAlD
Mesalazine—MPO—renal system—rectum cancer	0.00129	0.0298	CbGeAlD
Mesalazine—CHUK—lymph node—rectum cancer	0.00126	0.0293	CbGeAlD
Mesalazine—PPARG—epithelium—rectum cancer	0.00123	0.0285	CbGeAlD
Mesalazine—ALOX5—female reproductive system—rectum cancer	0.00122	0.0282	CbGeAlD
Mesalazine—PPARG—smooth muscle tissue—rectum cancer	0.00119	0.0275	CbGeAlD
Mesalazine—PPARG—renal system—rectum cancer	0.00114	0.0265	CbGeAlD
Mesalazine—PPARG—urethra—rectum cancer	0.00112	0.026	CbGeAlD
Mesalazine—PPARG—mammalian vulva—rectum cancer	0.00107	0.0247	CbGeAlD
Mesalazine—PPARG—female reproductive system—rectum cancer	0.000914	0.0212	CbGeAlD
Mesalazine—IKBKB—lymph node—rectum cancer	0.000859	0.0199	CbGeAlD
Mesalazine—PPARG—vagina—rectum cancer	0.000826	0.0192	CbGeAlD
Mesalazine—PTGS1—seminal vesicle—rectum cancer	0.000757	0.0176	CbGeAlD
Mesalazine—PTGS2—seminal vesicle—rectum cancer	0.000724	0.0168	CbGeAlD
Mesalazine—ALOX5—lymph node—rectum cancer	0.000712	0.0165	CbGeAlD
Mesalazine—PTGS1—epithelium—rectum cancer	0.000658	0.0152	CbGeAlD
Mesalazine—PTGS1—smooth muscle tissue—rectum cancer	0.000634	0.0147	CbGeAlD
Mesalazine—PTGS2—epithelium—rectum cancer	0.000629	0.0146	CbGeAlD
Mesalazine—PTGS1—renal system—rectum cancer	0.00061	0.0141	CbGeAlD
Mesalazine—PTGS2—smooth muscle tissue—rectum cancer	0.000606	0.014	CbGeAlD
Mesalazine—MPO—lymph node—rectum cancer	0.000602	0.014	CbGeAlD
Mesalazine—PTGS2—renal system—rectum cancer	0.000583	0.0135	CbGeAlD
Mesalazine—PTGS2—urethra—rectum cancer	0.000573	0.0133	CbGeAlD
Mesalazine—PTGS1—mammalian vulva—rectum cancer	0.00057	0.0132	CbGeAlD
Mesalazine—PPARG—lymph node—rectum cancer	0.000535	0.0124	CbGeAlD
Mesalazine—PTGS1—female reproductive system—rectum cancer	0.000489	0.0113	CbGeAlD
Mesalazine—PTGS2—female reproductive system—rectum cancer	0.000467	0.0108	CbGeAlD
Mesalazine—PTGS1—vagina—rectum cancer	0.000442	0.0102	CbGeAlD
Mesalazine—PTGS2—vagina—rectum cancer	0.000422	0.00979	CbGeAlD
Mesalazine—PTGS1—lymph node—rectum cancer	0.000286	0.00663	CbGeAlD
Mesalazine—PTGS2—lymph node—rectum cancer	0.000273	0.00633	CbGeAlD
Mesalazine—CHUK—Interleukin-11 Signaling Pathway—ITGA2—rectum cancer	0.00012	0.0493	CbGpPWpGaD
Mesalazine—IKBKB—Interleukin-11 Signaling Pathway—ITGA2—rectum cancer	0.000109	0.0447	CbGpPWpGaD
Mesalazine—MPO—C-MYB transcription factor network—NRAS—rectum cancer	3.66e-05	0.0151	CbGpPWpGaD
Mesalazine—IKBKB—GMCSF-mediated signaling events—NRAS—rectum cancer	3.51e-05	0.0144	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—TP53—rectum cancer	3.4e-05	0.014	CbGpPWpGaD
Mesalazine—MPO—C-MYB transcription factor network—KRAS—rectum cancer	3.15e-05	0.013	CbGpPWpGaD
Mesalazine—IKBKB—GMCSF-mediated signaling events—KRAS—rectum cancer	3.02e-05	0.0124	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD8+ T cells—NRAS—rectum cancer	2.9e-05	0.0119	CbGpPWpGaD
Mesalazine—CHUK—PDGF Pathway—HRAS—rectum cancer	2.72e-05	0.0112	CbGpPWpGaD
Mesalazine—MPO—C-MYB transcription factor network—HRAS—rectum cancer	2.68e-05	0.011	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD8+ T cells—NRAS—rectum cancer	2.63e-05	0.0108	CbGpPWpGaD
Mesalazine—IKBKB—GMCSF-mediated signaling events—HRAS—rectum cancer	2.57e-05	0.0106	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD8+ T cells—KRAS—rectum cancer	2.5e-05	0.0103	CbGpPWpGaD
Mesalazine—CHUK—Interleukin-11 Signaling Pathway—HRAS—rectum cancer	2.47e-05	0.0101	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TYMS—rectum cancer	2.46e-05	0.0101	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—NRAS—rectum cancer	2.44e-05	0.01	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—NRAS—rectum cancer	2.41e-05	0.0099	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	2.4e-05	0.00988	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD8+ T cells—KRAS—rectum cancer	2.27e-05	0.00932	CbGpPWpGaD
Mesalazine—IKBKB—Interleukin-11 Signaling Pathway—HRAS—rectum cancer	2.24e-05	0.0092	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—NRAS—rectum cancer	2.21e-05	0.00909	CbGpPWpGaD
Mesalazine—IKBKB—mTOR signaling pathway—NRAS—rectum cancer	2.21e-05	0.00909	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NRAS—rectum cancer	2.18e-05	0.00898	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD8+ T cells—HRAS—rectum cancer	2.12e-05	0.00874	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—KRAS—rectum cancer	2.1e-05	0.00863	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—KRAS—rectum cancer	2.07e-05	0.00852	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	1.93e-05	0.00793	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD8+ T cells—HRAS—rectum cancer	1.93e-05	0.00792	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—KRAS—rectum cancer	1.9e-05	0.00782	CbGpPWpGaD
Mesalazine—IKBKB—mTOR signaling pathway—KRAS—rectum cancer	1.9e-05	0.00782	CbGpPWpGaD
Mesalazine—CHUK—Fc-epsilon receptor I signaling in mast cells—HRAS—rectum cancer	1.9e-05	0.00781	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—KRAS—rectum cancer	1.88e-05	0.00773	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—NRAS—rectum cancer	1.87e-05	0.00768	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—ITGA2—rectum cancer	1.85e-05	0.00759	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—rectum cancer	1.84e-05	0.00758	CbGpPWpGaD
Mesalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—rectum cancer	1.83e-05	0.00754	CbGpPWpGaD
Mesalazine—CHUK—p75(NTR)-mediated signaling—TP53—rectum cancer	1.8e-05	0.0074	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—HRAS—rectum cancer	1.78e-05	0.00733	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—HRAS—rectum cancer	1.76e-05	0.00724	CbGpPWpGaD
Mesalazine—CHUK—BCR signaling pathway—HRAS—rectum cancer	1.76e-05	0.00724	CbGpPWpGaD
Mesalazine—IKBKB—Fc-epsilon receptor I signaling in mast cells—HRAS—rectum cancer	1.72e-05	0.00708	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—NRAS—rectum cancer	1.69e-05	0.00697	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—rectum cancer	1.67e-05	0.00687	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	1.66e-05	0.00682	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—NRAS—rectum cancer	1.64e-05	0.00676	CbGpPWpGaD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—TP53—rectum cancer	1.63e-05	0.00671	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—HRAS—rectum cancer	1.62e-05	0.00665	CbGpPWpGaD
Mesalazine—IKBKB—mTOR signaling pathway—HRAS—rectum cancer	1.62e-05	0.00665	CbGpPWpGaD
Mesalazine—CHUK—Leptin signaling pathway—HRAS—rectum cancer	1.61e-05	0.00662	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—KRAS—rectum cancer	1.61e-05	0.00661	CbGpPWpGaD
Mesalazine—IKBKB—BCR signaling pathway—HRAS—rectum cancer	1.6e-05	0.00657	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—HRAS—rectum cancer	1.6e-05	0.00657	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—TP53—rectum cancer	1.54e-05	0.00632	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—NRAS—rectum cancer	1.49e-05	0.00613	CbGpPWpGaD
Mesalazine—IKBKB—Leptin signaling pathway—HRAS—rectum cancer	1.46e-05	0.006	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—KRAS—rectum cancer	1.46e-05	0.006	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	1.42e-05	0.00585	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—KRAS—rectum cancer	1.41e-05	0.00582	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	1.41e-05	0.0058	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TP53—rectum cancer	1.39e-05	0.00573	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—HRAS—rectum cancer	1.39e-05	0.00572	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—HRAS—rectum cancer	1.37e-05	0.00562	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—NRAS—rectum cancer	1.33e-05	0.00546	CbGpPWpGaD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—HRAS—rectum cancer	1.31e-05	0.00539	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—rectum cancer	1.31e-05	0.00538	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—KRAS—rectum cancer	1.28e-05	0.00528	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—NRAS—rectum cancer	1.27e-05	0.00522	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—HRAS—rectum cancer	1.26e-05	0.00519	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—NRAS—rectum cancer	1.25e-05	0.00514	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—HRAS—rectum cancer	1.24e-05	0.0051	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—HRAS—rectum cancer	1.2e-05	0.00494	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—NRAS—rectum cancer	1.19e-05	0.00491	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—NRAS—rectum cancer	1.19e-05	0.0049	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—NRAS—rectum cancer	1.19e-05	0.00489	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—HRAS—rectum cancer	1.19e-05	0.00489	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—NRAS—rectum cancer	1.18e-05	0.00486	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—NRAS—rectum cancer	1.18e-05	0.00484	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NRAS—rectum cancer	1.16e-05	0.00477	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—KRAS—rectum cancer	1.14e-05	0.0047	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—NRAS—rectum cancer	1.11e-05	0.00455	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—NRAS—rectum cancer	1.11e-05	0.00455	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	1.11e-05	0.00455	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—NRAS—rectum cancer	1.1e-05	0.00451	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—KRAS—rectum cancer	1.09e-05	0.0045	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—HRAS—rectum cancer	1.09e-05	0.00448	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—NRAS—rectum cancer	1.09e-05	0.00447	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—NRAS—rectum cancer	1.08e-05	0.00445	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—KRAS—rectum cancer	1.08e-05	0.00445	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—KRAS—rectum cancer	1.08e-05	0.00443	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—rectum cancer	1.05e-05	0.00432	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—NRAS—rectum cancer	1.05e-05	0.0043	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—KRAS—rectum cancer	1.03e-05	0.00423	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—KRAS—rectum cancer	1.02e-05	0.00421	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—NRAS—rectum cancer	1.02e-05	0.00421	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—KRAS—rectum cancer	1.02e-05	0.00421	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—KRAS—rectum cancer	1.02e-05	0.00419	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—KRAS—rectum cancer	1.01e-05	0.00416	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	1e-05	0.00413	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	9.98e-06	0.0041	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—rectum cancer	9.8e-06	0.00403	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—HRAS—rectum cancer	9.71e-06	0.004	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—rectum cancer	9.61e-06	0.00395	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—HRAS—rectum cancer	9.55e-06	0.00393	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—KRAS—rectum cancer	9.53e-06	0.00392	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—KRAS—rectum cancer	9.53e-06	0.00392	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	9.53e-06	0.00392	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—KRAS—rectum cancer	9.44e-06	0.00388	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—KRAS—rectum cancer	9.36e-06	0.00385	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—KRAS—rectum cancer	9.32e-06	0.00383	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—HRAS—rectum cancer	9.29e-06	0.00382	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—NRAS—rectum cancer	9.29e-06	0.00382	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—HRAS—rectum cancer	9.15e-06	0.00376	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—rectum cancer	9.05e-06	0.00372	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—KRAS—rectum cancer	9.01e-06	0.0037	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	8.96e-06	0.00369	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—KRAS—rectum cancer	8.82e-06	0.00363	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—HRAS—rectum cancer	8.73e-06	0.00359	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—HRAS—rectum cancer	8.71e-06	0.00358	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—HRAS—rectum cancer	8.69e-06	0.00358	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—HRAS—rectum cancer	8.66e-06	0.00356	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—HRAS—rectum cancer	8.65e-06	0.00356	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	8.64e-06	0.00355	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—HRAS—rectum cancer	8.61e-06	0.00354	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	8.48e-06	0.00349	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—rectum cancer	8.44e-06	0.00347	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—rectum cancer	8.15e-06	0.00335	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—HRAS—rectum cancer	8.1e-06	0.00333	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	8.1e-06	0.00333	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—HRAS—rectum cancer	8.1e-06	0.00333	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—HRAS—rectum cancer	8.02e-06	0.0033	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—rectum cancer	8e-06	0.00329	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—KRAS—rectum cancer	7.99e-06	0.00329	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	7.97e-06	0.00328	CbGpPWpGaD
Mesalazine—IKBKB—Insulin Signaling—HRAS—rectum cancer	7.96e-06	0.00327	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—HRAS—rectum cancer	7.95e-06	0.00327	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—HRAS—rectum cancer	7.92e-06	0.00326	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—rectum cancer	7.69e-06	0.00316	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—TYMS—rectum cancer	7.69e-06	0.00316	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—NRAS—rectum cancer	7.67e-06	0.00315	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—NRAS—rectum cancer	7.54e-06	0.0031	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—HRAS—rectum cancer	7.49e-06	0.00308	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	7.34e-06	0.00302	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—rectum cancer	7.17e-06	0.00295	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—NRAS—rectum cancer	6.95e-06	0.00286	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—rectum cancer	6.94e-06	0.00285	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—NRAS—rectum cancer	6.84e-06	0.00281	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—HRAS—rectum cancer	6.79e-06	0.00279	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—KRAS—rectum cancer	6.6e-06	0.00271	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—KRAS—rectum cancer	6.49e-06	0.00267	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—KRAS—rectum cancer	5.98e-06	0.00246	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—KRAS—rectum cancer	5.88e-06	0.00242	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HRAS—rectum cancer	5.61e-06	0.00231	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—HRAS—rectum cancer	5.52e-06	0.00227	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	5.31e-06	0.00218	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—NRAS—rectum cancer	5.19e-06	0.00213	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—rectum cancer	5.09e-06	0.00209	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—HRAS—rectum cancer	5e-06	0.00206	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—TYMS—rectum cancer	4.76e-06	0.00196	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	4.72e-06	0.00194	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—KRAS—rectum cancer	4.46e-06	0.00184	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—NRAS—rectum cancer	4.3e-06	0.00177	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—NRAS—rectum cancer	4.13e-06	0.0017	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—NRAS—rectum cancer	3.9e-06	0.0016	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—HRAS—rectum cancer	3.79e-06	0.00156	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—NRAS—rectum cancer	3.74e-06	0.00154	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—KRAS—rectum cancer	3.7e-06	0.00152	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—KRAS—rectum cancer	3.55e-06	0.00146	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—KRAS—rectum cancer	3.36e-06	0.00138	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—TYMS—rectum cancer	3.33e-06	0.00137	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—KRAS—rectum cancer	3.22e-06	0.00133	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—HRAS—rectum cancer	3.15e-06	0.00129	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HRAS—rectum cancer	3.02e-06	0.00124	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—HRAS—rectum cancer	2.85e-06	0.00117	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HRAS—rectum cancer	2.74e-06	0.00113	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—TYMS—rectum cancer	2.65e-06	0.00109	CbGpPWpGaD
Mesalazine—CHUK—Immune System—NRAS—rectum cancer	2.5e-06	0.00103	CbGpPWpGaD
Mesalazine—CHUK—Disease—NRAS—rectum cancer	2.31e-06	0.000951	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—NRAS—rectum cancer	2.27e-06	0.000934	CbGpPWpGaD
Mesalazine—CHUK—Immune System—KRAS—rectum cancer	2.16e-06	0.000887	CbGpPWpGaD
Mesalazine—CHUK—Disease—KRAS—rectum cancer	1.99e-06	0.000819	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—KRAS—rectum cancer	1.95e-06	0.000804	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HRAS—rectum cancer	1.83e-06	0.000754	CbGpPWpGaD
Mesalazine—CHUK—Disease—HRAS—rectum cancer	1.69e-06	0.000696	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HRAS—rectum cancer	1.66e-06	0.000683	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NRAS—rectum cancer	1.62e-06	0.000666	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NRAS—rectum cancer	1.47e-06	0.000604	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—KRAS—rectum cancer	1.39e-06	0.000573	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NRAS—rectum cancer	1.37e-06	0.000563	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—KRAS—rectum cancer	1.26e-06	0.00052	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—rectum cancer	1.24e-06	0.00051	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HRAS—rectum cancer	1.18e-06	0.000487	CbGpPWpGaD
Mesalazine—PTGS2—Disease—KRAS—rectum cancer	1.18e-06	0.000485	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—rectum cancer	1.12e-06	0.000462	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HRAS—rectum cancer	1.07e-06	0.000442	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HRAS—rectum cancer	1e-06	0.000412	CbGpPWpGaD
